Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

DARK SECRETS: Earnings preview what to expect from edwards lifesciences report - The Real Truth

Irvine, California-based Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases in the United States and internationally. With a market cap of $45.3 billion, the company is set to unveil its second-quarter results on Thursday, July 24, after the market closes.

Ahead of the event, analysts expect EW to report non-GAAP earnings of $0.62 per share, down 11.4% from the profit of $0.70 per share reported in the year-ago quarter. Additionally, the company has surpassed or matched the Street’s bottom-line projections in each of the past four quarters, which is impressive.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.